The collaboration will integrate Palo Alto Networks' AI security platform, Prisma AIRS, with Google Cloud’s AI and ...
Vertex Pharmaceuticals recently reported clinical data showing that CASGEVY helped all evaluable children aged 5–11 with severe sickle cell disease or transfusion‑dependent beta thalassemia meet key ...
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY ® (exagamglogene autotemcel) in people ages 5 years and ...
--Currently up two consecutive days; up 7.5% over this period --Best two day stretch since the two days ending Dec. 14, 2023, when it rose 13.66% --Up 13.61% year-to-date; on pace for best year since ...
Vehicle platooning, first studied as an application of Intelligent Transportation Systems (ITS), is increasingly gaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback